ZYME vs. QLYS
ZYME (Zymeworks Inc.) and QLYS (Qualys, Inc.) are both stocks. ZYME operates in Biotechnology (Healthcare), while QLYS operates in Software - Infrastructure (Technology). Over the past 5 years, ZYME returned -8.24%/yr vs 2.00%/yr for QLYS. At a 0.17 correlation, their price movements are largely independent.
Performance
ZYME vs. QLYS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ZYME achieves a -9.30% return, which is significantly higher than QLYS's -15.48% return.
ZYME
- 1D
- 2.67%
- 1M
- -6.76%
- YTD
- -9.30%
- 6M
- -10.86%
- 1Y
- 91.50%
- 3Y*
- 43.33%
- 5Y*
- -8.24%
- 10Y*
- —
QLYS
- 1D
- 3.52%
- 1M
- 9.73%
- YTD
- -15.48%
- 6M
- -19.23%
- 1Y
- -19.98%
- 3Y*
- -3.38%
- 5Y*
- 2.00%
- 10Y*
- 14.09%
ZYME vs. QLYS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ZYME Zymeworks Inc. | -9.30% | 79.85% | 40.90% | 32.19% | -52.04% | -65.32% | 3.96% | 209.67% | 93.33% | -43.75% |
QLYS Qualys, Inc. | -15.48% | -5.22% | -28.56% | 74.89% | -18.21% | 12.60% | 46.18% | 11.55% | 25.93% | 55.57% |
Correlation
The correlation between ZYME and QLYS is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Apr 28, 2017 | 0.17 |
Fundamentals
ZYME:
$1.78B
QLYS:
$4.01B
ZYME:
-$583.41
QLYS:
$5.57
ZYME:
22.95
QLYS:
5.93
ZYME:
0.01
QLYS:
7.03
ZYME:
$78.86M
QLYS:
$684.86M
ZYME:
$77.16M
QLYS:
$569.03M
ZYME:
-$47.18B
QLYS:
$252.31M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ZYME vs. QLYS — Risk / Return Rank
ZYME
QLYS
ZYME vs. QLYS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Zymeworks Inc. (ZYME) and Qualys, Inc. (QLYS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ZYME | QLYS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.18 | ||
| Sortino ratioReturn per unit of downside risk | +3.08 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 0.95 | +0.38 |
| Calmar ratioReturn relative to maximum drawdown | 4.33 | -0.40 | +4.73 |
| Martin ratioReturn relative to average drawdown | 9.21 | -0.81 | +10.02 |
Loading charts...
Drawdowns
ZYME vs. QLYS - Drawdown Comparison
The maximum ZYME drawdown since its inception was -91.81%, which is greater than QLYS's maximum drawdown of -68.48%. Use the drawdown chart below to compare losses from any high point for ZYME and QLYS.
Loading charts...
Drawdown Indicators
| ZYME | QLYS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.81% | -68.48% | -23.33% |
Max Drawdown (1Y)Largest decline over 1 year | -21.25% | -50.46% | +29.21% |
Max Drawdown (3Y)Largest decline over 3 years | -45.75% | -62.99% | +17.24% |
Max Drawdown (5Y)Largest decline over 5 years | -87.53% | -62.99% | -24.54% |
Max Drawdown (10Y)Largest decline over 10 years | — | -62.99% | — |
Current DrawdownCurrent decline from peak | -57.97% | -45.44% | -12.53% |
Average DrawdownAverage peak-to-trough decline | -52.54% | -20.93% | -31.61% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.97% | 24.68% | -14.71% |
Volatility
ZYME vs. QLYS - Volatility Comparison
The current volatility for Zymeworks Inc. (ZYME) is 10.12%, while Qualys, Inc. (QLYS) has a volatility of 12.30%. This indicates that ZYME experiences smaller price fluctuations and is considered to be less risky than QLYS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ZYME | QLYS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.12% | 12.30% | -2.18% |
Volatility (6M)Calculated over the trailing 6-month period | 29.45% | 36.52% | -7.07% |
Volatility (1Y)Calculated over the trailing 1-year period | 52.91% | 45.62% | +7.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 61.85% | 39.93% | +21.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 61.45% | 39.07% | +22.38% |
Dividends
ZYME vs. QLYS - Dividend Comparison
Neither ZYME nor QLYS has paid dividends to shareholders.
Financials
ZYME vs. QLYS - Financials Comparison
This section allows you to compare key financial metrics between Zymeworks Inc. and Qualys, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ZYME and QLYS have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QLYS has higher volatility (12.30%) compared to ZYME (10.12%). In terms of maximum drawdown, ZYME dropped -91.81% vs QLYS's -68.48%.
ZYME currently has the higher Sharpe Ratio (1.74 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ZYME and QLYS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer